Cumberland Pharmaceuticals Inc — Rendiconto Finanziario Trimestrale (NASDAQ:CPIX) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 46.07 M
Employee 93
Founded 1999
CEO N/A
Website www.cumberlandpharma.com
Headquarter Tennessee, United States
FIGI BBG000R93GV7
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

46.07 M Capitalizzazione di mercato

Rapporto prezzo/utili

-20.95

Rapporto prezzo/fatturato

1.33

Notizie

Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales

Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript

Le azioni di Cumberland Pharmaceuticals salgono grazie allo status fast track della FDA

Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug

FDA fast tracks Cumberland’s DMD heart disease therapy

Niche Focus & Regulation Shape the Future of Healthcare Firms

Top Research Reports for NVIDIA, Netflix & Merck

Zacks Initiates Coverage of CPIX With Outperform Recommendation

Cumberland investe 4 milioni di dollari per una quota del 30% nell’attività Talicia di RedHill

Cumberland invests $4 million for 30% stake in RedHill’s Talicia business

Cumberland’s injectable ibuprofen receives approval in Mexico

Jones James acquista azioni Cumberland Pharmaceuticals (CPIX) per un valore di $861